在2025年的两项研究中,经常用户使用大麻与减少酒精摄入和肝病风险相关联。 Cannabis use linked to reduced alcohol intake and liver disease risk in frequent users, per two 2025 studies.

《美国精神病学杂志》2025年11月的一项研究发现,大麻吸食率为3.1%或7.2%的THC,这两种药物经常使用者的酒精消费量分别减少了19%和27%,这表明了一种短期替代效应。 A November 2025 study in The American Journal of Psychiatry found that smoking cannabis with 3.1% or 7.2% THC reduced alcohol consumption by 19% and 27% respectively in frequent users of both substances, suggesting a short-term substitution effect. 2025年10月在利物国际进行的一项单独研究将大麻的使用与33 114名酗酒紊乱者中与酒精有关的肝病风险降低40%联系起来,同时降低了肝脏损害和死亡风险。 A separate October 2025 study in Liver International linked cannabis use to a 40% lower risk of alcohol-associated liver disease among 33,114 individuals with alcohol use disorder, along with reduced risks of liver decompensation and death. 这两项研究均发现,酒精渴望或消费没有因使用大麻而增加,不过研究人员强调需要进一步研究,了解各种机制和潜在的医疗应用。 Both studies found no increase in alcohol cravings or consumption due to cannabis use, though researchers emphasized the need for further study to understand mechanisms and potential medical applications.